Similar articles

• [New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].

  Colao A, Pulcrano M, Dorato M, Müller F, Rossi FW, De Martino MC, Biondi B, Lombardi G. Colao A, et al. Minerva Endocrinol. 2001 Dec;26(4):231-8. Minerva Endocrinol. 2001. PMID: 11782708 Review. Italian.
• Gut neuroendocrine tumors.

  Hammond PJ, Bloom SR. Hammond PJ, et al. Curr Ther Endocrinol Metab. 1994;5:570-5. Curr Ther Endocrinol Metab. 1994. PMID: 7704795 No abstract available.
• [Neuroendocrine tumors of the pancreas. Natural history and therapeutic options].

  Wiedenmann B. Wiedenmann B. Gastroenterol Clin Biol. 2003 Mar;27(3 Suppl):S26-30. Gastroenterol Clin Biol. 2003. PMID: 12704290 Review. French. No abstract available.
• Surgical treatment of non-functioning pancreatic islet cell tumors.

  Kouvaraki MA, Solorzano CC, Shapiro SE, Yao JC, Perrier ND, Lee JE, Evans DB. Kouvaraki MA, et al. J Surg Oncol. 2005 Mar 1;89(3):170-85. doi: 10.1002/jso.20178. J Surg Oncol. 2005. PMID: 15719379 Review.
• ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.

  Akerström G, Falconi M, Kianmanesh R, Ruszniewski P, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. Akerström G, et al. Neuroendocrinology. 2009;90(2):203-8. doi: 10.1159/000225949. Epub 2009 Aug 28. Neuroendocrinology. 2009. PMID: 19713712 No abstract available.